Sekikaic acid and lobaric acid target a dynamic interface of the coactivator CBP/p300.
about
Direct and Propagated Effects of Small Molecules on Protein-Protein Interaction NetworksProtein lysine acetylation by p300/CBPOrdering a Dynamic Protein Via a Small-Molecule StabilizerA natural-product switch for a dynamic protein interfaceThe role of HTS in drug discovery at the University of Michigan.Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognition.Prepaying the entropic cost for allosteric regulation in KIXDissecting allosteric effects of activator-coactivator complexes using a covalent small molecule ligand.State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors.Identification, synthesis and evaluation of substituted benzofurazans as inhibitors of CREB-mediated gene transcription.Fragment screening and druggability assessment for the CBP/p300 KIX domain through protein-observed 19F NMR spectroscopy.Targeting transcription is no longer a quixotic questSequence context and crosslinking mechanism affect the efficiency of in vivo capture of a protein-protein interactionFrom Fuzzy to Function: The New Frontier of Protein-Protein Interactions.Targeting Unoccupied Surfaces on Protein-Protein Interfaces.Tuning Sulfur Oxidation States on Thioether-Bridged Peptide Macrocycles for Modulation of Protein Interactions.A Novel Class of Natural FXR Modulators with a Unique Mode of Selective Co-regulator Assembly.A Natural-Product Switch for a Dynamic Protein Interface
P2860
Q26784027-7FCB413C-AFB9-459F-BFBE-76D75092B4B7Q27021749-CBEF8657-0EB7-4324-91F2-83B9D8D25115Q27676154-A410A3BE-1C1A-4CE8-964F-D213FB2D9AC2Q27690221-90C29A3D-EFA1-4670-A68A-4B7D6F79CC25Q31147980-DE1D9734-6CAE-460E-B077-A1F72FF75EE1Q34035076-A0D0BACF-581B-462B-9A65-0C84A2BD3F6CQ34082751-7F58E8AD-87C5-4D3E-A6CC-0A8998EFE855Q34083040-A162B088-5A98-4DC8-9B3C-8330DE55B1B6Q35738960-28CF37DF-4068-4C7D-B138-D3ACB88DC56CQ37198882-B36F983F-AD1F-463D-9209-4801300583A4Q39043214-0F8C717B-ED9F-4851-AC7C-46DCBC3C8A42Q41552169-255A6AC1-5544-4F16-95D5-AB727FEB00B1Q42112672-A1F66153-0043-46EA-8569-9385E03B520CQ46522186-DC180599-37DF-431D-A360-73ECC86AA599Q48009055-744DC07A-9A88-47A5-83E8-D3F758B3ACE5Q48252469-D8E7A6A3-4341-45D5-93B5-71AD0715D9E1Q51142237-4A4DB05A-02FE-4614-8469-E162B7CA4079Q57531362-A68CCB5F-ACCD-42DD-8506-50F8362DE02A
P2860
Sekikaic acid and lobaric acid target a dynamic interface of the coactivator CBP/p300.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 October 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sekikaic acid and lobaric acid target a dynamic interface of the coactivator CBP/p300.
@en
Sekikaic acid and lobaric acid target a dynamic interface of the coactivator CBP/p300.
@nl
type
label
Sekikaic acid and lobaric acid target a dynamic interface of the coactivator CBP/p300.
@en
Sekikaic acid and lobaric acid target a dynamic interface of the coactivator CBP/p300.
@nl
prefLabel
Sekikaic acid and lobaric acid target a dynamic interface of the coactivator CBP/p300.
@en
Sekikaic acid and lobaric acid target a dynamic interface of the coactivator CBP/p300.
@nl
P2093
P2860
P356
P1476
Sekikaic acid and lobaric acid target a dynamic interface of the coactivator CBP/p300.
@en
P2093
Anna K Mapp
Carl J Arevang
Charles L Brooks
Chinmay Y Majmudar
Conor H Doss
David H Sherman
Jessica K Gagnon
Laura C Cesa
Pamela J Schultz
Steven P Rowe
P2860
P304
11258-11262
P356
10.1002/ANIE.201206815
P407
P577
2012-10-08T00:00:00Z